 | Up a level |
Awasthi, Rakesh, Mueller, Karen Thudium, Yanik, Gregory A., Tam, Constantine Si Lun, Rives, Susana, McGuirk, Joseph, Boyer, Michael W., Jager, Ulrich, Baruchel, Andre, Myers, Gary Douglas, Borchmann, Peter, Jaglowski, Samantha Mary, Stefanski, Heather E., Bishop, Michael Russell, Waldron, Edward K., Hamilton, Jason, Cota, Mariana, Bubuteishvili-Pacaud, Lida and Waller, Edmund K. (2018). Considerations for tisagenlecleucel dosing rationale. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Mueller, Karen Thudium, Grupp, Stephan A., Maude, Shannon L., Levine, John E., Pulsipher, Michael, Boyer, Michael W., August, Keith Jason, Myers, Gary Douglas, Awasthi, Rakesh, Waldron, Edward K., Bubuteishvili-Pacaud, Lida, Taran, Tanya, Cota, Mariana, Tam, Constantine Si Lun, Jager, Ulrich, Foley, Ronan, Borchmann, Peter, Schuster, Stephen J., Waller, Edmund K. and Laetsch, Theodore Willis (2018). Immunogenicity of tisagenlecleucel in relapsed/ refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL) patients. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755